Safety and efficacy of an extract containing Panax ginseng (ginseng) and Lepidium meyenii (maca).
Not Applicable
- Conditions
- Erectile Dysfunction
- Registration Number
- JPRN-UMIN000009405
- Lead Sponsor
- DHC Corporation
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- Male
- Target Recruitment
- 30
Inclusion Criteria
Not provided
Exclusion Criteria
- Subjects who have an inappropriate clinical history for efficacy and safety assessment in the study (such as drug abuse, alcoholism, and the disease of heart, liver, kidney, lungs, eye, blood etc) and who is taking any drugs. - Subjects judged to be inappropriate for the study by the investigator.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
What are the molecular mechanisms by which Panax ginseng and Lepidium meyenii extracts improve erectile dysfunction in clinical trials?
How does the combination of ginseng and maca compare to PDE5 inhibitors like sildenafil in treating erectile dysfunction?
Are there specific biomarkers that predict response to ginseng and maca extract therapy for erectile dysfunction?
What are the potential adverse events associated with long-term use of Panax ginseng and Lepidium meyenii combination therapy?
What is the therapeutic potential of ginseng and maca extracts compared to other herbal combination therapies for erectile dysfunction?